Article Versions Notes

Parigi TL, Vieujean S, Paridaens K, Dalgaard K, Peyrin-Biroulet L, Danese S. Efficacy, Safety, and Concerns on Microbiota Modulation, Antibiotics, Probiotics, and Fecal Microbial Transplant for Inflammatory Bowel Disease and Other Gastrointestinal Conditions: Results from an International Survey. Microorganisms. 2023; 11(11):2806. https://doi.org/10.3390/microorganisms11112806

Parigi, Tommaso Lorenzo, Sophie Vieujean, Kristine Paridaens, Kira Dalgaard, Laurent Peyrin-Biroulet, and Silvio Danese. 2023. "Efficacy, Safety, and Concerns on Microbiota Modulation, Antibiotics, Probiotics, and Fecal Microbial Transplant for Inflammatory Bowel Disease and Other Gastrointestinal Conditions: Results from an International Survey" Microorganisms 11, no. 11: 2806. https://doi.org/10.3390/microorganisms11112806

Parigi, T. L., Vieujean, S., Paridaens, K., Dalgaard, K., Peyrin-Biroulet, L., & Danese, S. (2023). Efficacy, Safety, and Concerns on Microbiota Modulation, Antibiotics, Probiotics, and Fecal Microbial Transplant for Inflammatory Bowel Disease and Other Gastrointestinal Conditions: Results from an International Survey. Microorganisms, 11(11), 2806. https://doi.org/10.3390/microorganisms11112806